IL-35 administration prevented the development of T1D and reversed established T1D, maybe by recruiting more iTR35 cells and increasing the expression of Eos in Treg cells to maintain the regulatory T cell phenotype. The gene discussed is IKZF4; the disease is type 1 diabetes mellitus.